The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Biosimilars in the Antitrust Spotlight: Patent Litigation and Settlement" on October 4, 2018 from 2:00 to 3:00 pm (ET). Nicholas Mitrokostas of Goodwin Procter LLP, Richard Mortimer of Anaylsis Group, and Michael Perry of Baker Botts LLP will discuss:
• The likely shape of settlements in patent litigation between innovator biologic companies and biosimilar aspirants
• In light of FTC challenges to a series of contemporaneous business deals including patent settlements, the future of non-cash forms of compensation
• As multiple patents in biosimilar infringement litigation can be asserted in staggered waves over time, whether “at-risk” entry is more or less likely than for traditional generic drugs
The registration fee for the webinar is $135 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.